| Literature DB >> 35719666 |
Abstract
Background: Telemedicine as a tool that can reduce potential disease spread and fill a gap in healthcare has been increasingly applied during the COVID-19 pandemic. Many studies have summarized telemedicine's technologies or the diseases' applications. However, these studies were reviewed separately. There is a lack of a comprehensive overview of the telemedicine technologies, application areas, and medical service types. Objective: We aimed to investigate the research direction of telemedicine at COVID-19 and to clarify what kind of telemedicine technology is used in what diseases, and what medical services are provided by telemedicine.Entities:
Keywords: COVID-19; bibliometric analysis; eHealth; network analysis; telemedicine
Mesh:
Year: 2022 PMID: 35719666 PMCID: PMC9199898 DOI: 10.3389/fpubh.2022.908756
Source DB: PubMed Journal: Front Public Health ISSN: 2296-2565
Figure 1Research design framework.
Top 10 journals are publishing research on telemedicine research in COVID-19.
|
|
|
|
|
|
|---|---|---|---|---|
| 1 | Journal of Medical Internet Research | Canada | 5.428 | 166 |
| 2 | Telemedicine Journal and e-health | United States | 1.297 | 118 |
| 3 | International Journal of Environmental Research and Public Health | Nigeria | 3.390 | 93 |
| 4 | PLoS One | United States | 3.240 | 64 |
| 5 | JMIR mHealth and uHealth | Canada | 4.773 | 58 |
| 6 | Journal of Diabetes Science and Technology | United States | None | 43 |
| 7 | Journal of the American Medical Informatics Association | England | 4.497 | 43 |
| 8 | Indian Journal of Ophthalmology | India | 1.848 | 41 |
| 9 | Asian Journal of Psychiatry | Netherlands | 3.543 | 37 |
| 10 | Frontiers in Public Health | Switzerland | 3.709 | 37 |
Figure 2The cooperation of countries/regions in telemedicine at COVID-19.
Top 10 cited references in telemedicine research in COVID-19.
|
|
|
|
|
|
|
|---|---|---|---|---|---|
| 32160451 | Virtually Perfect? Telemedicine for COVID-19 | 2020 | 314 | New England Journal of Medicine | 91.253 |
| 31986264 | Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China | 2020 | 121 | Lancet | 79.323 |
| 32196391 | telemedicine for global emergencies: Implications for coronavirus disease 2019 (COVID-19) | 2020 | 109 | Journal of Telemedicine and Telecare | 6.184 |
| 32109013 | Clinical Characteristics of Coronavirus Disease 2019 in China | 2020 | 106 | New England Journal of Medicine | 91.253 |
| 32091533 | Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72 314 Cases From the Chinese Center for Disease Control and Prevention | 2020 | 102 | JAMA-Journal of The American Medical Association | 56.274 |
| 32165352 | Video consultations for COVID-19 | 2020 | 93 | BMJ-British Medical Journal | 39.89 |
| 32171076 | Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study | 2020 | 86 | Lancet | 79.323 |
| 32324855 | COVID-19 transforms health care through telemedicine: Evidence from the field | 2020 | 84 | Journal of the American Medical Informatics Association | 4.497 |
| 32031570 | Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China | 2020 | 81 | JAMA-Journal of the American Medical Association | 56.274 |
| 32066541 | Cancer patients in SARS-CoV-2 infection: a nationwide analysis in China | 2020 | 81 | Lancet Oncology | 41.316 |
Figure 3Matrix visualization of bi-clustering of the cited-citing matrix.
Top 10 TF-IDF values of MAJR in each cluster.
|
|
|
|
|
|---|---|---|---|
| 0 | 1 | Mental disorders/epidemiology | 0.002010 |
| 2 | Mental disorders/psychology | 0.001608 | |
| 3 | Mental health | 0.001335 | |
| 4 | Crisis intervention/methods | 0.001311 | |
| 5 | Psychotic disorders/therapy | 0.001311 | |
| 6 | Mental health/trends | 0.001311 | |
| 7 | Behavior therapy/standards | 0.001311 | |
| 8 | Mental disorders/prevention and control | 0.001311 | |
| 9 | Adaptation, psychological | 0.001268 | |
| 10 | Social support | 0.001206 | |
| 1 | 1 | Contact tracing/ethics | 0.003682 |
| 2 | Contact tracing/instrumentation | 0.002455 | |
| 3 | Contact tracing | 0.002137 | |
| 4 | Privacy | 0.001899 | |
| 5 | Contact tracing/statistics and numerical data | 0.001841 | |
| 6 | Mobile applications/statistics and numerical data | 0.001528 | |
| 7 | Disease notification/methods | 0.001227 | |
| 8 | Pandemics/ethics | 0.001227 | |
| 9 | Confidentiality/ethics | 0.001227 | |
| 10 | Population surveillance/methods | 0.001227 | |
| 2 | 1 | Technology | 0.001924 |
| 2 | Visual acuity | 0.001569 | |
| 3 | Abortion, induced/methods | 0.001569 | |
| 4 | Orthopedic procedures | 0.001443 | |
| 5 | Orthopedics/methods | 0.001214 | |
| 6 | Eye diseases/diagnosis | 0.001065 | |
| 7 | Artificial intelligence/trends | 0.000962 | |
| 8 | Traumatology/methods | 0.000962 | |
| 9 | Ophthalmology/organization and administration | 0.000962 | |
| 10 | Reconstructive surgical procedures/methods | 0.000962 | |
| 3 | 1 | Cross infection/prevention and control | 0.000925 |
| 2 | Antineoplastic agents/therapeutic use | 0.000755 | |
| 3 | Defibrillators, implantable | 0.000755 | |
| 4 | Clinical trials as topic | 0.000755 | |
| 5 | Inflammatory bowel diseases/epidemiology | 0.000755 | |
| 6 | Coronavirus infections/immunology | 0.000755 | |
| 7 | Hospitalization/statistics and numerical data | 0.000617 | |
| 8 | Neoplasms/radiotherapy | 0.000617 | |
| 9 | Infection control/standards | 0.000584 | |
| 10 | Monitoring, physiologic/methods | 0.000512 | |
| 4 | 1 | Primary health care/methods | 0.000903 |
| 2 | Endovascular procedures/methods | 0.000700 | |
| 3 | Kidney failure, chronic/therapy | 0.000700 | |
| 4 | Neurosurgical procedures/methods | 0.000700 | |
| 5 | Dermatology/education | 0.000700 | |
| 6 | Primary health care/trends | 0.000700 | |
| 7 | Hypersensitivity/therapy | 0.000572 | |
| 8 | Skin diseases/diagnosis | 0.000572 | |
| 9 | Inflammatory bowel diseases/therapy | 0.000572 | |
| 10 | Remote consultation/organization and administration | 0.000542 | |
| 5 | 1 | Physical therapists | 0.778151 |
| 2 | Health services | 0.778151 | |
| 3 | Urologic diseases/epidemiology | 0.778151 | |
| 4 | Workflow | 0.778151 | |
| 5 | Academic medical centers | 0.778151 | |
| 6 | Medical informatics applications | 0.477121 | |
| 7 | Physician-patient relations | 0.477121 | |
| 8 | Urology | 0.301030 | |
| 9 | Chronic pain/therapy | 0.477121 | |
| 10 | General practice | 0.477121 |
Entity extraction results.
|
|
|
|
|
|---|---|---|---|
|
| |||
| Information science category | L | 30 | |
|
| |||
| Diseases category | C | 75 | |
| Behavior and behavior mechanisms | F01 | ||
| Mental disorders | F03 | ||
|
| |||
| Delivery of health care | N04.590.374 | 205 | |
| Health services | N02.421 | ||
| Public health | N06.850 | ||
Figure 4Technology entity nodes and other node connections in the network.
Figure 5Common diseases with IT entities network.
Figure 6Neoplasm node and other nodes connections in the network.
Figure 7Mental disorders node and other nodes connections in the network.
Figure 8Diabetes mellitus node and other nodes connections in the network.